The firm plans to send its containerised mRNA factories—which it calls Biontainers—to parts of the world which lack their own vaccine-manufacturing capabilities https://t.co/IeaXGz0e3K
— The Economist (@TheEconomist) February 18, 2022
Source: Twitter
Share this:
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.